Search results
Showing results for
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end of 2020.
In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.
Journal article
Reiné J. et al, (2026), Comput Biol Chem, 122
Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.
Journal article
Hysa A. et al, (2026), PLoS Med, 23
Predicting trajectories of illness using RNA velocity of whole blood.
Journal article
Dunican C. et al, (2026), Nat Commun, 17
"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".
Journal article
Noronha IH. et al, (2026), J Infect Dis
Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.
Journal article
Jones E. et al, (2026), J Immunol, 215
African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.
Journal article
Muriuki JM. et al, (2026), Nat Commun
Securing the future of immunisation: ESCMID's vision.
Journal article
Ramasamy MN. et al, (2026), Clin Microbiol Infect, 32, 516 - 518
Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.
Journal article
Walker J. et al, (2026), PLoS Negl Trop Dis, 20
Maternal views on RSV vaccination in the UK's second season.
Journal article
O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211
Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
Journal article
Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 379 - 434
Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.
Journal article
Yusuf S. et al, (2026), Lancet Infect Dis, 26, e259 - e267
Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.
Journal article
Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 494 - 513
The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.
Journal article
Zhang Y. et al, (2026), EClinicalMedicine, 94
Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules
Thesis / Dissertation
Kelly E., (2026)
Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.
Journal article
Weight CM. et al, (2026), J Infect Dis
Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.
Journal article
Turan G. et al, (2026), Vaccines (Basel), 14
Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.
Journal article
Bijukchhe SM. et al, (2026), Lancet Infect Dis
Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.
Journal article
Cheliotis KS. et al, (2026), Vaccine, 75
13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.
Journal article
Tembo G. et al, (2026), Vaccine, 75
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.
Journal article
Hausdorff WP. et al, (2026), Vaccine, 75